Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroquel XR for the Management of Borderline Personality Disorder (BPD)

NCT00880919 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT00880919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00880919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroquel XR for the Management of Borderline Personality Disorder (BPD)
Lead sponsor
University of Minnesota
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
March 31, 2013
Enrollment
95 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder